Fast-Acting Depression Drug, Newly Approved, Could Help Millions [nytimes.com]
Of the 16 million American adults who live with depression, as many as one-quarter gain little or no benefit from available treatments, whether drugs or talk therapy. They represent perhaps the greatest unmet need in psychiatry. On Tuesday, the Food and Drug Administration approved a prescription treatment intended to help them, a fast-acting drug derived from an old and widely used anesthetic, ketamine. The move heralds a shift from the Prozac era of antidepressant drugs. The newly approved...